Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Haskill, S., Beg, A. A., Tompkins, S. M., Morris, J. S., Yurochko, A. D., Sampson-Johannes, A., Mondal, K., Ralph, P., & Baldwin, A. S. (1991) · Cell · doi:10.1016/0092-8674(91)90022-q · Cited by 732
NF-κB Activation: The IκB Kinase Revealed?
Stancovski, I., & Baltimore, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80413-4 · Cited by 492
Beg, A. A., Sha, W. C., Bronson, R. T., & Baltimore, D. (1995) · Genes & Development · doi:10.1101/gad.9.22.2736 · Cited by 473
Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M. S., Bachelerie, F., Thomas, D., & Hay, R. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2689 · Cited by 433
Self-citationAutoregulation of I kappa B alpha activity.
Chiao, P. J., Miyamoto, S., & Verma, I. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.28 · Cited by 423
IκBα Deficiency Results in a Sustained NF-κB Response and Severe Widespread Dermatitis in Mice
Klement, J. F., Rice, N. R., Car, B. D., Abbondanzo, S. J., Powers, G. D., Bhatt, H., Chen, C.-H., Rosen, C. A., & Stewart, C. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2341 · Cited by 340
de Martin, R., Vanhove, B., Cheng, Q., Hofer, E., Csizmadia, V., Winkler, H., & Bach, F. H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05938.x · Cited by 331
IκB proteins: structure, function and regulation
Whiteside, S. T., & Israël, A. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0058 · Cited by 324
Le Bail, O., Schmidt-Ullrich, R., & Israël, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06197.x · Cited by 323
Cotranslational Biogenesis of NF-κB p50 by the 26S Proteasome
Lin, L., DeMartino, G. N., & Greene, W. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81409-9 · Cited by 312
High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
Bargou, R., Leng, C., Krappmann, D., Emmerich, F., Mapara, M., Bommert, K., Royer, H., Scheidereit, C., & Dorken, B. (1996) · Blood · doi:10.1182/blood.v87.10.4340.bloodjournal87104340 · Cited by 309
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
Krappmann, D., Emmerich, F., Kordes, U., Scharschmidt, E., Dörken, B., & Scheidereit, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202351 · Cited by 271
Rel/NF-κB transcription factors and the control of apoptosis
Sonenshein, G. E. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0062 · Cited by 238
JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action?
Karin, M., & Delhase, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9067 · Cited by 214
Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-κB
Kitajima, I., Shinohara, T., Bilakovics, J., Brown, D. A., Xu, X., & Nerenberg, M. (1992) · Science · doi:10.1126/science.1299224 · Cited by 212
IκB kinase: Beginning, not the end
Verma, I. M., & Stevenson, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.11758 · Cited by 198
Recent Results on the Biology of Hodgkin and Reed-Sternberg cells: II. Continuous Cell Lines
Drexler, H. G. (1993) · Leukemia & Lymphoma · doi:10.3109/10428199309148499 · Cited by 172
Correction of Radiation Sensitivity in Ataxia Telangiectasia Cells by a Truncated IκB-α
Jung, M., Zhang, Y., Lee, S., & Dritschilo, A. (1995) · Science · doi:10.1126/science.7777860 · Cited by 171
Rel/NF-κB and IκB factors in oncogenesis
Luque, I., & Gélinas, C. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0061 · Cited by 142
Sylla, B. S., Hung, S. C., Davidson, D. M., Hatzivassiliou, E., Malinin, N. L., Wallach, D., Gilmore, T. D., Kieff, E., & Mosialos, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10106 · Cited by 137
Defective IκBα in Hodgkin cell lines with constitutively active NF-κB
Wood, K. M., Roff, M. A., & Hay, R. T. (1998) · Oncogene · doi:10.1038/sj.onc.1201735 · Cited by 127
Self-citationDomain Organization of IκBα and Sites of Interaction with NF-κB p65
Jaffray, E., Wood, K. M., & Hay, R. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2166 · Cited by 121
Self-citationTroelstra, C., Hesen, W., Bootsma, D., & Hoeijmakers, J. H. J. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.3.419 · Cited by 74
Cited by
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
NF-kB in development and progression of human cancer
Dolcet, X., Llobet, D., Pallares, J., & Matias-Guiu, X. (2005) · Virchows Archiv · doi:10.1007/s00428-005-1264-9 · Cited by 1,169
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421358 · Cited by 1,033
Metadata
- Authors
- Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F., & Hay, R. T.
- Venue
- Oncogene
- Published
- 1999-05-20
- Volume
- 18
- Issue
- 20
- Pages
- 3063-3070
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2291321734
- Cited by
- 334
- References
- 26
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.